<?xml version="1.0" encoding="UTF-8"?>
<p>Characterizing HIV drug resistance using the AHI/RHI method is likely to give a more representative estimate [
 <xref rid="pone.0171124.ref010" ref-type="bibr">10</xref>,
 <xref rid="pone.0171124.ref019" ref-type="bibr">19</xref>,
 <xref rid="pone.0171124.ref034" ref-type="bibr">34</xref>,
 <xref rid="pone.0171124.ref036" ref-type="bibr">36</xref>]. We assessed HIV-1 TDR level in treatment-na√Øve persons with AHI/RHI in an ARV-exposed rural setting in western Kenya that has both high HIV incidence and prevalence [
 <xref rid="pone.0171124.ref037" ref-type="bibr">37</xref>,
 <xref rid="pone.0171124.ref038" ref-type="bibr">38</xref>].
</p>
